These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
683 related items for PubMed ID: 15950101
21. Whole-body MR imaging of bone marrow. Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A. Eur J Radiol; 2005 Jul; 55(1):33-40. PubMed ID: 15950099 [Abstract] [Full Text] [Related]
23. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M. J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607 [Abstract] [Full Text] [Related]
24. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. Hillengass J, Fechtner K, Weber MA, Bäuerle T, Ayyaz S, Heiss C, Hielscher T, Moehler TM, Egerer G, Neben K, Ho AD, Kauczor HU, Delorme S, Goldschmidt H. J Clin Oncol; 2010 Mar 20; 28(9):1606-10. PubMed ID: 20177023 [Abstract] [Full Text] [Related]
25. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity. Kloth JK, Hillengass J, Listl K, Kilk K, Hielscher T, Landgren O, Delorme S, Goldschmidt H, Kauczor HU, Weber MA. Int J Cancer; 2014 Nov 15; 135(10):2380-6. PubMed ID: 24706394 [Abstract] [Full Text] [Related]
26. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A, Kauczor HU, Ho AD, Goldschmidt H, Moehler TM. Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):475-81. PubMed ID: 17255268 [Abstract] [Full Text] [Related]
27. [Infiltration patterns of plasmacytomas in magnetic resonance tomography]. Baur A, Stäbler A, Bartl R, Lamerz R, Reiser M. Rofo; 1996 Jun 15; 164(6):457-63. PubMed ID: 8688501 [Abstract] [Full Text] [Related]
29. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma. Layer G, Steudel A, Schüller H, van Kaick G, Grünwald F, Reiser M, Schild HH. Cancer; 1999 Feb 15; 85(4):1004-9. PubMed ID: 10091781 [Abstract] [Full Text] [Related]
30. Histomorphology of multiple myeloma on bone marrow biopsy. Singhal N, Singh T, Singh ZN, Shome DK, Gaiha M. Indian J Pathol Microbiol; 2004 Jul 15; 47(3):359-63. PubMed ID: 16295424 [Abstract] [Full Text] [Related]
31. [MR tomography of the bone marrow changes after high-dosage chemotherapy and autologous peripheral stem-cell transplantation]. Pereira PL, Schick F, Einsele H, Farnsworth CT, Kollmansberger C, Mattke A, Duda SH, Claussen CD. Rofo; 1999 Mar 15; 170(3):251-7. PubMed ID: 10230433 [Abstract] [Full Text] [Related]
32. MRI of bone tumors: Fast STIR imaging as a substitute for T1-weighted contrast-enhanced fat-suppressed spin-echo imaging. Tokuda O, Hayashi N, Matsunaga N. J Magn Reson Imaging; 2004 Apr 15; 19(4):475-81. PubMed ID: 15065172 [Abstract] [Full Text] [Related]
33. Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation. Song MK, Chung JS, Lee JJ, Min CK, Ahn JS, Lee SM, Shin DY, Bae SH, Hong J, Lee GW, Lee IS, Shin HJ. Br J Haematol; 2014 Jun 15; 165(6):777-85. PubMed ID: 24628463 [Abstract] [Full Text] [Related]
34. [Aspects and role of spinal MRI in the assessment of solitary plasmacytoma and multiple myeloma. Apropos of 11 cases]. Lafforgue P, Clairet D, Chagnaud C, Toussirot E, Daumen-Legre V, Schiano A, Bayle O, Kasbarian M, Acquaviva PC. Rev Rhum Mal Osteoartic; 1992 May 15; 59(5):317-26. PubMed ID: 1411192 [Abstract] [Full Text] [Related]
35. [Malignant bone marrow infiltration in nuclear magnetic resonance tomography]. Gamillscheg A, Urban C, Ranner G, Kaulfersch W, Lackner H, Hauer C, Slavc I, Schmid G. Padiatr Padol; 1989 May 15; 24(2):103-11. PubMed ID: 2761997 [Abstract] [Full Text] [Related]
36. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI. D'Anastasi M, Notohamiprodjo M, Schmidt GP, Dürr HR, Reiser MF, Baur-Melnyk A. AJR Am J Roentgenol; 2014 Oct 15; 203(4):854-62. PubMed ID: 25247952 [Abstract] [Full Text] [Related]
37. Bone marrow transplantation in patients with multiple myeloma: prognostic significance of MR imaging. Lecouvet FE, Dechambre S, Malghem J, Ferrant A, Vande Berg BC, Maldague B. AJR Am J Roentgenol; 2001 Jan 15; 176(1):91-6. PubMed ID: 11133544 [Abstract] [Full Text] [Related]
38. [The nuclear magnetic tomographic diagnosis of focal lesions of the red bone marrow. The optimization of the acquisition parameters for GE and SE sequences]. Seiderer M, Wagner H, Stäbler A, Fink U. Rofo; 1994 May 15; 160(5):453-8. PubMed ID: 8173055 [Abstract] [Full Text] [Related]
39. MR imaging of multiple myeloma in tumour mass measurement at diagnosis and during treatment. Carlson K, Aström G, Nyman R, Ahlström H, Simonsson B. Acta Radiol; 1995 Jan 15; 36(1):9-14. PubMed ID: 7833177 [Abstract] [Full Text] [Related]
40. Tumor infiltration of bone marrow in patients with hemato-logical malignancies: dynamic contrast-enhanced magnetic resonance imaging. Zhang L, Mandel C, Yang ZY, Yang Q, Nibbs R, Westerman D, Pitman A. Chin Med J (Engl); 2006 Aug 05; 119(15):1256-62. PubMed ID: 16919184 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]